Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
2018 · Nature Medicine · 1,688 citations
https://doi.org/10.1038/s41591-018-0101-z
Y
Young Suk Park
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
298
Papers
10.7K
Citations
50
h-index
161
i10-index
Young Suk Park is an academic researcher from Samsung Medical Center. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Gastric Cancer Management and Outcomes & Pancreatic and Hepatic Oncology Research. The author has an h-index of 50, co-authored 254 publications.
ORCID: 0000-0002-2900-0421Papers by this author
worksOxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial
2014 · The Lancet Oncology · 384 citations
https://doi.org/10.1016/s1470-2045(14)70377-8
Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial
2019 · Cancer Discovery · 222 citations
https://doi.org/10.1158/2159-8290.cd-19-0442
A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis
2014 · Investigational New Drugs · 66 citations
https://doi.org/10.1007/s10637-013-0059-0
Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer
2011 · Radiation Oncology · 48 citations
https://doi.org/10.1186/1748-717x-6-52
Serum <scp>CA</scp>19–9, cathepsin <scp>D</scp>, and matrix metalloproteinase‐7 as a diagnostic panel for pancreatic ductal adenocarcinoma
2012 · PROTEOMICS · 42 citations
https://doi.org/10.1002/pmic.201200101
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat